Top

Published in:

01-09-2009 | Case Report

Lung parenchymal consolidation as an uncommon presentation and cause of delayed diagnosis in atypical Kawasaki syndrome

Authors: Francesco De Maddi, Roberto Cinelli, Donato Rigante, Gianfranco Mazzarella, Paolo Siani

Published in: Rheumatology International | Issue 11/2009

Abstract

We report three patients who initially showed prolonged fever, lung parenchymal consolidation and laboratory findings of pneumonia, and secondarily presented a clinical picture ascribed to Kawasaki syndrome. Two of these children developed coronary artery dilations, which regressed upon echocardiography after 12 months. In the case of infants showing broncho-pulmonary abnormalities with slow resolution, active inflammatory parameters and high fever persistence, pediatricians should consider atypical Kawasaki syndrome as a possible alternative diagnosis.

Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Committee on Rheumatic Fever, Endocarditis, Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association et al (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young American Heart Association. Pediatrics 114:1708–1733. doi:10.1542/peds.2004-2182 PubMedCrossRef

Rowley AH, Shulman ST (2007) New developments in the search for the etiologic agent of Kawasaki disease. Curr Opin Pediatr 19:71–74. doi:10.1097/MOP.0b013e328012720f PubMedCrossRef

Terai M, Shulman ST (1997) Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gammaglobulin dose but independent of salicylate dose. J Pediatr 131:888–893. doi:10.1016/S0022-3476(97)70038-6 PubMedCrossRef

Uziel Y, Hashkes PJ, Kassem E, Gottesman G, Wolach B (2003) “Unresolving pneumonia” as the main manifestation of atypical Kawasaki disease. Arch Dis Child 88:940–942. doi:10.1136/adc.88.10.940 PubMedCrossRef

Voynow JA, Schanberg L, Sporn T, Kredich D (2002) Pulmonary complications associated with Kawasaki disease. J Pediatr 140:786–787. doi:10.1067/mpd.2002.pd124772 PubMedCrossRef

Freeman AF, Crawford SE, Finn LS, López-Andreu JA, Ferrando-Monleón S, Pérez-Tamarit D et al (2003) Inflammatory pulmonary nodules in Kawasaki disease. Pediatr Pulmonol 36:102–106. doi:10.1002/ppul.10333 PubMedCrossRef

Kobayashi Y, Koike Y, Tokutomi T, Kuroki Y, Todoroki I (2006) Case 2: fever, rash and pulmonary involvement, diagnosis: Kawasaki disease. Acta Paediatr 95:1145–1148. doi:10.1080/08035250600686953 PubMedCrossRef

Sengler C, Gaedicke G, Wahn U, Keitzer R (2004) Pulmonary symptoms in Kawasaki disease. Pediatr Infect Dis J 23:782–784. doi:10.1097/01.inf.0000134313.86697.20 PubMedCrossRef

Umezawa T, Saji T, Matsuo N, Odagiri K (1989) Chest X-ray findings in the acute phase of Kawasaki disease. Pediatr Radiol 20:48–51. doi:10.1007/BF02010633 PubMedCrossRef

10.

Falcini F, Cimaz R, Calabri GB, Picco P, Martini G, Marazzi MG et al (2002) Kawasaki’s disease in northern Italy: a multicenter retrospective study of 250 patients. Clin Exp Rheumatol 20:421–426PubMed

11.

Yasukawa K, Terai M, Shulman ST, Toyozaki T, Yajima S, Kohno Y et al (2002) Systemic production of vascular endothelial growth factor and fms-like tyrosine kinase-1 receptor in acute Kawasaki disease. Circulation 105:709–766. doi:10.1161/hc0602.103396 CrossRef

12.

Rowley AH, Baker SC, Shulman ST, Fox LM, Takahashi K, Garcia FL et al (2005) Cytoplasmic inclusion bodies are detected by synthetic antibody in ciliated bronchial epithelium during acute Kawasaki disease. J Infect Dis 192:1757–1766. doi:10.1086/497171 PubMedCrossRef

13.

Rowley AH, Shulman ST, Garcia FL, Guzman-Cottrill JA, Miura M, Lee HL et al (2005) Cloning the arterial IgA antibody response during acute Kawasaki disease. J Immunol 175:8386–8391PubMed

14.

Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, Kawasaki Disease Research Committee et al (2005) Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int 47:232–234. doi:10.1111/j.1442-200x.2005.02033.x PubMedCrossRef

15.

Rosenfeld EA, Corydon KE, Shulman ST (1995) Kawasaki disease in infants less than 1 year of age. J Pediatr 126:524–529. doi:10.1016/S0022-3476(95)70344-6 PubMedCrossRef

16.

Genizi J, Miron D, Spiegel R, Fink D, Horowitz Y (2003) Kawasaki disease in very young infants: high prevalence of atypical presentation and arteritis. Clin Pediatr 42:263–267. doi:10.1177/000992280304200310 CrossRef

17.

Anderson MS, Todd JK, Glodé MP (2005) Delayed diagnosis of Kawasaki syndrome: an analysis of the problem. Pediatrics 115:e428–e433. doi:10.1542/peds.2004-1824 PubMedCrossRef

Title: Lung parenchymal consolidation as an uncommon presentation and cause of delayed diagnosis in atypical Kawasaki syndrome
Authors: Francesco De Maddi
Roberto Cinelli
Donato Rigante
Gianfranco Mazzarella
Paolo Siani
Publication date: 01-09-2009
Publisher: Springer-Verlag
Published in: Rheumatology International / Issue 11/2009
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-008-0830-2

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 11/2009

Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis

The many faces of sarcoidosis: asymptomatic muscle mass mimicking giant-cell tumor

Increased frequency of familial Mediterranean fever in northern Turkey: a population-based study

Adding low dose tacrolimus in rheumatoid arthritis patients with an inadequate response to tumor necrosis factor inhibitor therapies

Treatment outcomes in patients with non-infectious aortic valvulitis undergoing aortic valve replacement: implication for the treatment of aortic valve involvement in Behcet’s disease

The use of etanercept in a patient with disseminated tuberculosis

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials